Change appears to be coming for diabetes care. The HbA1c test may not be the safest approach for diabetics to follow in preventing complications. Instead, experts are saying the average blood glucose level per individual will add clarity to diabetic patients looking to manage their disease.

A study supporting the change showed a close correlation between average glucose and HbA1c levels. So the myth, busted is: maintaining an average blood sugar is a safer approach for diabetes management -- NOT CHASING A UNIFORM HbA1c value. The fluctuation in blood sugar is what causes complications in the small vessels of the eyes, kidneys and peripheral nerve endings. For example - sustaining a blood sugar of 200 mg/dL is a lot safer than waking at 240 and ushering a boatload of sugar into your cells to drop your sugar to 80 mg/dL. It is the transfer of glucose into the cell that causes the injury to cell membranes and resulting complications.

Think of it like the movement of the ocean. High tide to low tide happens gradually, over the course of many hours throughout the day. When a storm hits - the waves become turbulent, crashing against the shore causing erosion. Is the human body any different? I'm not a doctor -- but I did stay at a Holiday Inn Express last week.

Yes, that's what it says: curbing the diabetic epidemic with 6 oat waters. CeaProve® is a new test for the early detection of pre-diabetes or impaired glucose tolerance that may help curb the diabetes epidemic. For those of you who have endured a glucose tolerance test - you'll understand the pivotal importance of this new diagnostic test. Ceapro has developed a test that identifies people at risk of type-2 diabetes as early as 5 to 10 years before the disease is diagnosed.

The simple test involves eating 6 oat-wafers and undergoing a finger prick. The test - when repeated at six month intervals - can also show if lifestyle changes are being effective or if more treatment is needed. Ceapro has tested CeaProve in the workplace of several prominent businesses in Edmonton that are interested in helping their employees monitor and preserve their health. Over 90% of tested volunteers were unaware of their risk for diabetes. Of the population studied, 60% were overweight, 56% were over the age of 40, 44 % had a family history of diabetes and over 57% had more than two risk factors for the disease. Although Ceapro is a Canadian-based company, they expect to have Ceaprove available in commercial quantities within the next 45 days. The product will likely be released through regional health initiatives and may also be available through pharmacies and medical laboratories.

Can such a simple test have such a significant impact on the future of one's health? The results tell people, years ahead of time if they are heading down the path to diabetes. With dietary modifications, regular exercise, and an overall improve in lifestyle - wouldn't it be worth it to you?